The DOI matches its Crossref record.
Plasminogen Activator Inhibitor-1 Is a Major Determinant of Arterial Thrombolysis Resistance
Abstract
Background —Platelet-rich thrombi are resistant to lysis by tissue plasminogen activator (tPA). Plasminogen activator inhibitor-1 (PAI-1), a rapid inhibitor of tPA, may contribute to arterial thrombolysis resistance. However, few data are available regarding the effect of PAI-1 on arterial thrombolysis in animals. We used a murine carotid injury model to test the hypothesis that PAI-1 inhibits thrombolysis mediated by pharmacological concentrations of tPA. Methods and Results —Platelet-rich thrombi were induced in wild-type mice ( PAI-1 +/+; n=11) and PAI-1–deficient mice ( PAI-1 −/−; n=11) with ferric chloride. Baseline carotid blood flows and mean occlusion times did not differ between PAI-1 +/+ and PAI-1 −/− mice. Clot lysis was induced by infusion of heparin (200 U/kg bolus, 70 U · kg −1 · h −1 drip), human plasminogen (50 mg/kg), and tPA at 20 (n=10) or 100 (n=12) μg · kg −1 · min −1 . Mean plasma tPA antigens were 2.7 μg/mL (tPA infusion, 20 μg · kg −1 · min −1 ) and 5.5 μg/mL (tPA infusion, 100 μg · kg −1 · min −1 ), with no significant differences between PAI-1 +/+ mice and PAI-1 −/− mice. Reperfusion after tPA 20 μg · kg −1 · min −1 occurred in 1 of 5 PAI-1 +/+ mice versus 5 of 5 PAI-1 −/− mice ( P =0.0006). Reperfusion occurred in all mice that received tPA 100 μg · kg −1 · min −1 , but reperfusion times were significantly shorter in PAI-1 −/− mice (17.8±2.6 minutes, n=6) than in PAI-1 +/+ mice (35.7±5.1 minute, n=6; P =0.01). Histological analyses confirmed that carotid thrombi were platelet rich and that PAI-1 was distributed uniformly throughout thrombi from PAI-1 +/+ mice. Lysates of PAI-1 +/+ platelets inhibited human tPA, whereas PAI-1 −/− platelet lysates did not. Conclusions —PAI-1 is a major determinant of the resistance of platelet-rich arterial thrombi to lysis by pharmacological concentrations of tPA. Strategies to inhibit or resist PAI-1 may enhance thrombolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
Kohler, H. P., & Grant, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422406 · Cited by 806
Collet, J. P., Allali, Y., Lesty, C., Tanguy, M. L., Silvain, J., Ankri, A., Blanchet, B., Dumaine, R., Gianetti, J., Payot, L., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000241589.52950.4c · Cited by 348
Antidote-mediated control of an anticoagulant aptamer in vivo
Rusconi, C. P., Roberts, J. D., Pitoc, G. A., Nimjee, S. M., White, R. R., Quick, G., Scardino, E., Fay, W. P., & Sullenger, B. A. (2004) · Nature Biotechnology · doi:10.1038/nbt1023 · Cited by 339
Self-citationPleiotropic functions of plasminogen activator inhibitor-1
LIJNEN, H. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00827.x · Cited by 312
WANG, X., CHENG, Q., XU, L., FEUERSTEIN, G. Z., HSU, M., SMITH, P. L., SEIFFERT, D. A., SCHUMACHER, W. A., OGLETREE, M. L., & GAILANI, D. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01236.x · Cited by 278
Metadata
- Authors
- Zhu, Y., Carmeliet, P., & Fay, W. P.
- Venue
- Circulation
- Published
- 1999-06-15
- Volume
- 99
- Issue
- 23
- Pages
- 3050-3055
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2062969878
- Cited by
- 184
- References
- 0
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasminogen Activator Inhibitor-1 Is a Major Determinant of Arterial Thrombolysis Resistance. https://app.cochat.ai/papers/10.1161/01.cir.99.23.3050
- The paper
- Zhu, Y., Carmeliet, P., & Fay, W. P. (1999). Plasminogen Activator Inhibitor-1 Is a Major Determinant of Arterial Thrombolysis Resistance. Circulation. https://doi.org/10.1161/01.cir.99.23.3050
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.